EUEAL BIOTECH Trademark

Trademark Overview


On Friday, May 27, 2022, a trademark application was filed for EUEAL BIOTECH with the United States Patent and Trademark Office. The USPTO has given the EUEAL BIOTECH trademark a serial number of 97432258. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Sunday, April 6, 2025. This trademark is owned by N-CELL CO., LTD.. The EUEAL BIOTECH trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceutical preparations for therapeutic and medical purposes for prevention and treatment of cancer, cardiovascular diseases, hypertension, atherosclerosis, ischemia, aneurysms, ictus, infarction, angina, stroke, cerebrovascular accidents, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), sclerosis of the hippocampus, epilepsy, focal sclerosis, adrenoleukodystrophy, leukodystrophy, vascular dementia, senile dementia, headaches, migraine headaches, central nervous system trauma, sleep disorders, dizziness, pain, depression, anxiety, drug and alcohol addictions, blindness, hearing problems, disorientation, altered mood, obesity, overweightness, metabolic disorders, hypercholesterolemia, hypertriglyceridemia, hyperglycaemia, diabetes, inflammatory diseases, infectious diseases, and autoimmune diseases; pharmaceutical preparations for the prevention of diseases in the immune system; health food supplements; cru...
eueal biotech

General Information


Serial Number97432258
Word MarkEUEAL BIOTECH
Filing DateFriday, May 27, 2022
Status760 - EX PARTE APPEAL PENDING
Status DateSunday, April 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "EUEAL" in bold font, followed by the wording "BIOTECH" below.
Goods and ServicesNutraceutical preparations for therapeutic and medical purposes for prevention and treatment of cancer, cardiovascular diseases, hypertension, atherosclerosis, ischemia, aneurysms, ictus, infarction, angina, stroke, cerebrovascular accidents, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), sclerosis of the hippocampus, epilepsy, focal sclerosis, adrenoleukodystrophy, leukodystrophy, vascular dementia, senile dementia, headaches, migraine headaches, central nervous system trauma, sleep disorders, dizziness, pain, depression, anxiety, drug and alcohol addictions, blindness, hearing problems, disorientation, altered mood, obesity, overweightness, metabolic disorders, hypercholesterolemia, hypertriglyceridemia, hyperglycaemia, diabetes, inflammatory diseases, infectious diseases, and autoimmune diseases; pharmaceutical preparations for the prevention of diseases in the immune system; health food supplements; crude medicines, namely, medicines for treating neurological disease, muscular disease, ischemic disease, renal disease, and cancer; dietary supplemental nutritive substances being dietary supplements; nutraceuticals for use as a dietary supplement; dietetic preparations adapted for medical purposes, namely, dietetic food supplements; dietary and nutritionally fortified food being dietetic foods adapted for medical purposes; food supplements for medical purposes; nutritionally fortified beverages for medical purposes; all cannabidiol-containing items are solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis
Pseudo MarkEUEAL BIO TECH; EUEAL BIOTECHNOLOGY; EUEAL BIO TECHNOLOGY
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"BIOTECH"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 26, 2023
Primary Code005
First Use Anywhere DateWednesday, November 30, 2022
First Use In Commerce DateWednesday, November 30, 2022

Trademark Owner History


Party NameN-CELL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChungcheongbuk-do 27721
KR

Party NameN-CELL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChungcheongbuk-do 27721
KR

Trademark Events


Event DateEvent Description
Tuesday, October 4, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, May 31, 2022NEW APPLICATION ENTERED
Friday, June 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 15, 2023ASSIGNED TO EXAMINER
Tuesday, March 21, 2023PRIORITY ACTION WRITTEN
Tuesday, March 21, 2023PRIORITY ACTION E-MAILED
Tuesday, March 21, 2023NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, June 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 26, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, June 26, 2023EXAMINERS AMENDMENT E-MAILED
Monday, June 26, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 26, 2023EXAMINER'S AMENDMENT ENTERED
Monday, July 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 30, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, January 30, 2024USE AMENDMENT FILED
Wednesday, February 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 21, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, February 26, 2024ASSIGNED TO EXAMINER
Wednesday, February 28, 2024ASSIGNED TO EXAMINER
Saturday, March 2, 2024SU - NON-FINAL ACTION - WRITTEN
Saturday, March 2, 2024NON-FINAL ACTION E-MAILED
Saturday, March 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, September 29, 2024ASSIGNED TO LIE
Friday, October 4, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 4, 2024FINAL REFUSAL E-MAILED
Friday, October 4, 2024SU - FINAL REFUSAL - WRITTEN
Monday, January 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 18, 2025ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Monday, January 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 6, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, January 6, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, January 6, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, April 6, 2025EXPARTE APPEAL RECEIVED AT TTAB
Sunday, April 6, 2025EX PARTE APPEAL-INSTITUTED
Saturday, January 18, 2025NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Saturday, January 18, 2025ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED